Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy

Jpn J Ophthalmol. 2012 Jan;56(1):52-9. doi: 10.1007/s10384-011-0095-2. Epub 2011 Oct 19.

Abstract

Purpose: To evaluate the effectiveness of selective photocoagulation (S-PC) for nonperfusion areas (NPA) in preproliferative diabetic retinopathy (PPDR).

Subjects and methods: A multicenter randomized controlled clinical trial of 69 patients with PPDR showing NPA comparable to or larger than those on reference photographs. The patients were assigned to 2 groups; one was treated with S-PC (PC group: 32 patients), while the other did not receive S-PS (non-PC group: 37 patients). In the non-PC group, panretinal photocoagulation (PRP) was performed whenever proliferative diabetic retinopathy (PDR) developed. In the PC group, S-PC of the NPA was performed followed by additional coagulation whenever the NPA extended, and PRP was performed whenever PDR developed. The primary outcome was the development of PDR.

Results: During the entire course, PDR developed in 18 (26%) of the 69 patients. The incidence was significantly higher in the non-PC group than in the PC group. Comparison of the visual acuity at the time of registration and after 36 months showed no significant differences between the two groups.

Conclusions: S-PC for NPA in PPDR is effective at preventing PDR development.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetic Retinopathy / etiology
  • Diabetic Retinopathy / prevention & control*
  • Diabetic Retinopathy / surgery
  • Disease Progression
  • Female
  • Fluorescein Angiography
  • Humans
  • Incidence
  • Laser Coagulation*
  • Male
  • Middle Aged
  • Retina / surgery*
  • Treatment Outcome
  • Visual Acuity / physiology